News & Events
-
October 15, 2015
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines
Schito M, Migliori GB, Fletcher HA, McNerney R, Centis R, D’Ambrosio L, Bates M, Kibiki G, Kapata N, Corrah T, Bomanji J, Vilaplana C, Johnson D, Mwaba P, Maeurer M, Zumla A. Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines. Clin Infectious Dis. 2015;61(suppl 3):S102–18.
-
October 15, 2015
Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done
Schito M, Maeurer M, Kim P, Hanna D, Zumla A. Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done. Clin Infectious Dis. 2015;61(suppl 3):S95–101.
- October 13, 2015
-
October 1, 2015
A Collaborative Approach for “ReSeq-Ing” Mycobacterium Tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers
Schito M, Dolinger DL. A Collaborative Approach for “ReSeq-Ing” Mycobacterium Tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers. EBioMedicine. 2015 Oct;2(10):1262–5.
-
October 1, 2015
Global Collaboration to Develop New and Existing Drugs for Neonates
Davis JM, Turner MA. Global Collaboration to Develop New and Existing Drugs for Neonates. JAMA pediatrics. 2015 Oct;169(10):887–8....
